MilliporeSigma Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. ABBV
4. DFTX
5. FRVO
6. CART
7. RGNX
8. HIVE
9. MPLT
10. INTC

Go back to MilliporeSigma Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies
(AMEX: MKKGY) Delayed: 30.75 --0 (-0%)
Previous Close $30.75    52 Week High $ 
Open $30.75    52 Week Low $ 
Day High $30.75    P/E N/A 
Day Low $30.75    EPS $ 
Volume 33       

Merck & Co. (NYSE: MRK) Delayed: 113.87 --0 (-0%)
Previous Close $113.87    52 Week High $65.46 
Open $113.87    52 Week Low $47.97 
Day High $113.87    P/E 77.46 
Day Low $113.87    EPS $1.47 
Volume 35,949